Newsgather

Abete

Estable183 noticias17 fuentesÚltima actualización: ayer

Últimas noticias

AK Parti'den Booking.com'un Türkiye'ye dönüşüne yeşil ışık
En desarrollo
Política·2/8/2026Resumen IA

AK Parti'den Booking.com'un Türkiye'ye dönüşüne yeşil ışık

AK Parti, 2017'den beri yasaklı olan Booking.com ve diğer dijital konaklama platformlarının Türkiye'de yeniden faaliyet göstermesini sağlayacak bir yasa teklifi hazırladı. Teklif, platformlara vergi mükellefiyeti, turizm payı ödeme, düşük komisyon kuralları ve şeffaf algoritma taahhüdü gibi yeni mali ve hukuki yükümlülükler getiriyor.

M
Milliyet Son Dakika
2 min de lectura
Australia warns on Ozempic, Mounjaro eye disorder risk
En desarrollo
Salud·24/7/2026Resumen IA

Australia warns on Ozempic, Mounjaro eye disorder risk

Australia's Therapeutic Goods Administration (TGA) has warned about a "rare but severe" eye disorder, non-arteritic anterior ischaemic optic neuropathy (NAION), linked to type 2 diabetes and obesity treatments like Ozempic and Mounjaro. The warning, based on 36 reported cases, advises patients to seek urgent medical attention for sudden vision loss but not to stop treatment without consulting a doctor.

G
Guardian World
3 min de lectura
Novo Nordisk Sues Eli Lilly Over 'Misleading' Weight-Loss Drug Ads
En desarrollo
Business·22/7/2026Resumen IA

Novo Nordisk Sues Eli Lilly Over 'Misleading' Weight-Loss Drug Ads

Novo Nordisk is suing Eli Lilly, alleging "false and misleading" advertisements for its weight-loss and anti-diabetes treatments, Zepbound and Mounjaro. Novo Nordisk claims Lilly used outdated studies comparing its highest doses against lower doses of Novo Nordisk's drugs, creating a deceptive impression of superiority. Eli Lilly defends its ads, citing the Surmount-5 trial as the only direct comparison.

G
Guardian Business
1 min de lectura
ADA Deputy Editors Publish Preprint After Organization Refuses to Run Critical Articles on New Orleans Incident
En desarrollo
Ciencia·19/7/2026Resumen IA

ADA Deputy Editors Publish Preprint After Organization Refuses to Run Critical Articles on New Orleans Incident

Deputy editors of Diabetes Care have released a preprint containing an editorial and seven opinion pieces after the American Diabetes Association refused to publish them. The articles detail new allegations surrounding the removal of five prominent scientists from the ADA's annual meeting in New Orleans for distributing criticism of the Trump administration's attacks on scientific research.

A
Ars Technica
7 min de lectura